Table 2. Odds ratios and 95% confidence intervals for the association between epigenetic age acceleration (using 3 different measures) and the risk of lung cancer in the CLUE II study.
Age acceleration measure | OR (95% CI)* | p-value* |
AA_Hannum | ||
Q1 | 1 (ref.) | |
Q2 | 0.96 (0.55, 1.66) | 0.88 |
Q3 | 0.74 (0.42, 1.30) | 0.29 |
Q4 | 0.74 (0.42, 1.31) | 0.31 |
Continuous (per 1 SD) | 0.82 (0.64, 1.05) | 0.12 |
AA_Horvath | ||
Q1 | 1 (ref.) | |
Q2 | 0.80 (0.46, 1.41) | 0.45 |
Q3 | 0.65 (0.37, 1.16) | 0.15 |
Q4 | 0.76 (0.43, 1.33) | 0.33 |
Continuous (per 1 SD) | 0.85 (0.68, 1.07) | 0.17 |
AA_Pheno | ||
Q1 | 1 (ref.) | |
Q2 | 0.61 (0.33, 1.11) | 0.10 |
Q3 | 0.79 (0.44, 1.40) | 0.42 |
Q4 | 0.89 (0.51, 1.56) | 0.69 |
Continuous (per 1 SD) | 0.92 (0.76, 1.10) | 0.36 |
IEAA_Hannum | ||
Q1 | 1 (ref.) | |
Q2 | 0.74 (0.42, 1.31) | 0.30 |
Q3 | 0.62 (0.35, 1.10) | 0.10 |
Q4 | 0.70 (0.40, 1.24) | 0.22 |
Continuous (per 1 SD) | 0.87 (0.67, 1.14) | 0.33 |
IEAA_Horvath | ||
Q1 | 1 (ref.) | |
Q2 | 0.52 (0.28, 0.94) | 0.031 |
Q3 | 0.84 (0.48, 1.47) | 0.54 |
Q4 | 0.82 (0.47, 1.42) | 0.47 |
Continuous (per 1 SD) | 0.93 (0.73, 1.19) | 0.58 |
IEAA_Pheno | ||
Q1 | 1 (ref.) | |
Q2 | 0.75 (0.42, 1.35) | 0.33 |
Q3 | 0.92 (0.52, 1.65) | 0.79 |
Q4 | 0.87 (0.49, 1.55) | 0.64 |
Continuous (per 1 SD) | 0.90 (0.74, 1.10) | 0.30 |
Abbreviations: IEAA: Intrinsic epigenetic age acceleration; ref.: referent. *Conditional logistic regression models, adjusting for batch effects, BMI, and smoking predicted pack years (using DNA methylation).